COSCIENS Biopharma Inc. (TSX:CSCI)

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.50M USD in the quarter ending March 31, 2025, a decrease of -27.08%. This brings the company's revenue in the last twelve months to $9.03M, up 127.46% year-over-year. In the year 2024, COSCIENS Biopharma had annual revenue of $9.59M with 34.22% growth.

• Revenue (ttm): $9.03M
• Revenue Growth: +127.46%
• P/S Ratio: 1.14
• Revenue / Employee: $225.75K
• Employees: 40
• Market Cap: 14.85M CAD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.59M	2.44M	34.22%
Dec 31, 2023	7.14M	-7.43M	-50.98%
Dec 31, 2022	14.57M	9.31M	177.03%
Dec 31, 2021	5.26M	1.61M	44.03%
Dec 31, 2020	3.65M	3.12M	586.47%